Intravenous injection of toxic shock syndrome toxin-1 (TSST-1) produce
d by Staphylococcus aureus, can reactivate arthritis in a rat ankle jo
int that has been previously inflamed by injection of peptidoglycan-po
lysaccharide polymers isolated from the cell walls of group A streptoc
occi. The severity and chronicity of this renewed arthritis is dose de
pendent and at higher doses (125 mug/kg) a prolonged joint inflammatio
n with pannus formation and marginal erosion of cartilage and bone is
induced after a single injection of TSST-1. Only modest synovial hyper
plasia is induced in control ankle joints by systemic injection of TSS
T-1. Another superantigen, streptococcal pyrogenic exotoxin induces a
much weaker, acute reactivation of arthritis that resolves by 2 days.
Repeated injections of TSST-1 at 7-day intervals give the same undimin
ished pattern of joint response, but the joint swelling persists at a
higher level with each succeeding injection. Cyclosporin A suppresses
all phases of the recurrent arthritis, indicating that TSST-1 could be
functioning through its property of a superantigen activating T lymph
ocytes. Il-1 receptor antagonist and anti-TNF-alpha neutralizing antib
ody, which reduce reactivation of arthritis by peptidoglycan-polysacch
aride polymers, have no effect on reactivation by TSST-1. This experim
ental model provides a means to examine in vivo the possible role of s
uperantigens in rheumatoid arthritis and related diseases, and to anal
yze the cellular and molecular pathways induced by this family of micr
obial products.